About Transcription factor MafA
Transcription factor MafA (MAFA) is a protein
from Homo sapiens identified by UniProt accession
Q8NHW3, 353 residues long.
MolForge cross-references it against 0 known binders and
68 disease associations.
Target properties
| Protein name | Transcription factor MafA |
| UniProt accession | Q8NHW3 |
| Gene | MAFA |
| Organism | Homo sapiens |
| Length | 353 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (68)
Diseases linked to this target (Open Targets).
- islet cell adenomatosis · score 0.53
- high density lipoprotein cholesterol measurement · score 0.22
- juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome · score 0.12
- MODY · score 0.10
- apolipoprotein A 1 measurement · score 0.09
- type 2 diabetes mellitus · score 0.08
- type 1 diabetes mellitus · score 0.08
- hyperinsulinism due to INSR deficiency · score 0.07
- hyperinsulinism due to glucokinase deficiency · score 0.07
- diabetes mellitus, transient neonatal, 2 · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NHW3-F1 | alphafold | PREDICTED | 61.54 | — |
Amino-acid sequence (353 residues)
MAAELAMGAE LPSSPLAIEY VNDFDLMKFE VKKEPPEAER FCHRLPPGSL SSTPLSTPCS SVPSSPSFCA PSPGTGGGGG AGGGGGSSQA GGAPGPPSGG PGAVGGTSGK PALEDLYWMS GYQHHLNPEA LNLTPEDAVE ALIGSGHHGA HHGAHHPAAA AAYEAFRGPG FAGGGGADDM GAGHHHGAHH AAHHHHAAHH HHHHHHHHGG AGHGGGAGHH VRLEERFSDD QLVSMSVREL NRQLRGFSKE EVIRLKQKRR TLKNRGYAQS CRFKRVQQRH ILESEKCQLQ SQVEQLKLEV GRLAKERDLY KEKYEKLAGR GGPGSAGGAG FPREPSPPQA GPGGAKGTAD FFL
Explore Transcription factor MafA with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets